Research - Cambridge, Massachusetts, United States
Cargene is developing oligonucleotide therapeutics across oncology, cardiovascular and fibrotic diseases. With sites in Boston, Singapore and Shanghai, Cargene combines proprietary chemistry with novel biology platforms. Cargene was founded by experienced biotech entrepreneurs XQ Lin, Yann Chong Tan, Professor Torsten Wuestefeld, and is advised by a world-class SAB including Professors Harvey Lodish, Jiahai Shi, Roger Foo and Kosh Ray.
Outlook
Varnish
Wix
Mobile Friendly
Google Cloud Hosting